Pancreatic Cancer Research

ResearcherSoochow UniversityNo recent work listed

Xiaohui Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5724-0799; OpenAlex author ID A5038207493. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. miR-18a and miR-106a Signatures in Plasma Small EVs Are Promising Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/ijms24087215↗
  2. The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells. Co-author DOI 10.2147/dddt.s242557↗
  3. Role of non-coding RNAs in pancreatic cancer: the bane of the microworld. First author DOI 10.3748/wjg.v20.i28.9405↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Katherine Teresa Morris · 1 shared paper, 2023 · strength 0.24
  2. Kritisha Bhandari · 1 shared paper, 2023 · strength 0.24
  3. Wei‐Qun Ding · 1 shared paper, 2023 · strength 0.24
  4. Shuyu Zhang · 2 shared papers, 2014–2020 · strength 0.15
  5. Jianping Cao · 2 shared papers, 2014–2020 · strength 0.15
  6. Zhenyu Wang · 1 shared paper, 2020 · strength 0.11
  7. Yiting Tang · 1 shared paper, 2014 · strength 0.04
  8. Jun Hao · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.